Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes

Circulation Research
G KojdaE Noack

Abstract

Whether organic nitrates are bioactivated to NO in cardiac muscle cells and may thus directly affect cardiac contractile function has remained an open question. Therefore, we determined the effects of the organic nitrates glyceryl trinitrate (100 mumol/L), pentaerythritol tetranitrate (10 mumol/L), and isosorbide-5-mononitrate on electrically stimulated contractile response (CR) and cAMP and cGMP content of isolated adult rat ventricular cardiomyocytes compared with different concentrations of the spontaneous NO donors S-nitroso-N-acetyl-d,1-penicillamine (SNAP) and 2,2-diethyl-1-hydroxy-1-nitroso-hydrazine (DEA/NO). A high concentration of spontaneous NO donors (100 mumol/L caused a large increase in cGMP content that was accompanied by a decrease in CR to 73.8 +/- 6.7% (SNAP) and 80.9 +/- 6.1% (DEA/NO) of the control values. Inhibition of cGMP-dependent protein kinase by 10 mumol/L KT 5822 converted this effect into a pronounced improvement of CR (163.5 +/- 14.0%) By contrast, the organic nitrates caused a small but significant increase in cGMP, which was accompanied by an increase in cAMP and CR identical to that induced by 10 nmol/L isoprenaline (141.6 +/- 6.4%) A similar effect was observed with a low concentration (1 mumo...Continue Reading

References

Nov 5, 1976·Pflügers Archiv : European journal of physiology·W Trautwein, G Trube
Dec 7, 1977·Biochemical and Biophysical Research Communications·J DiamondA J Trapani
Feb 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiJ Vane
Nov 13, 1992·European Journal of Pharmacology·R E KlabundeU Förstermann
Jan 1, 1991·Basic Research in Cardiology·E Noack, M Feelisch
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P F MéryR Fischmeister
Apr 1, 1989·Pflügers Archiv : European journal of physiology·R C LeviR Fischmeister
Oct 1, 1987·Journal of Molecular and Cellular Cardiology·R E WeishaarH R Kaplan
Jan 1, 1988·Methods in Enzymology·L H BotelhoB Jastorff
Jan 30, 1987·Biochemical and Biophysical Research Communications·H KaseM Kaneko
Sep 1, 1988·Journal of Molecular and Cellular Cardiology·H M PiperP Schwartz
Jul 1, 1982·Journal of Molecular and Cellular Cardiology·H M PiperP G Spieckermann
Jul 1, 1994·Journal of Applied Physiology·T LechevalierR G Kilbourn
Jan 1, 1995·The American Journal of Physiology·G M Wahler, S J Dollinger
Jan 9, 1993·Lancet·A J de BelderS Moncada
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J L BalligandT Michel
Sep 23, 1994·Cell·H H Schmidt, U Walter
May 1, 1994·Circulation Research·A M ShahE G Lakatta
May 1, 1994·The American Journal of Physiology·R Grocott-MasonA M Shah
Jul 1, 1993·The American Journal of Physiology·A J BradyS E Harding

❮ Previous
Next ❯

Citations

Sep 2, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Gerald MünzelKlaus-Dieter Schlüter
Feb 12, 2011·Heart and Vessels·Kursat DericiEmine Demirel-Yilmaz
Feb 5, 2009·Basic Research in Cardiology·Mark Hünlich, Gerd Hasenfuss
Jan 7, 2009·European Journal of Applied Physiology·Shigeo Kawada, Naokata Ishii
Mar 31, 2004·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·A R WhiteR J Walker
Sep 28, 2005·International Journal of Cardiology·Kazuki NakajimaTakeshi Nakano
Sep 13, 2003·European Journal of Pharmacology·Adrian AuSusan E Howlett
Jun 24, 2003·Journal of Molecular and Cellular Cardiology·Joshua M Hare
May 30, 2002·Life Sciences·Xiaoxing YinJean-Pierre Bourreau
May 7, 2003·Progress in Biophysics and Molecular Biology·Barbara Casadei, Claire E Sears
Apr 13, 2000·Pharmacology & Therapeutics·A M Shah, P A MacCarthy
Jun 12, 2003·Journal of the American College of Cardiology·Senta MüllerGeorg Kojda
Dec 1, 2001·Free Radical Biology & Medicine·M WeberG Kojda
Mar 10, 2001·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·G FroldiL Caparrotta
Sep 19, 2003·Vascular Pharmacology·Eva Kottenberg-AssenmacherGeorg Kojda
Feb 12, 1998·British Journal of Pharmacology·G KojdaE Noack
May 25, 2002·British Journal of Pharmacology·J W WegenerH Nawrath
Dec 17, 2003·Current Opinion in Hematology·Li GongScott A Waldman
Jul 20, 2005·Clinical and Experimental Pharmacology & Physiology·Matthew I WorthleyChristopher J Zeitz
Jun 5, 2002·Congestive Heart Failure·Gaurav Choudhary, Samuel C Dudley
Jan 1, 1997·Annual Review of Physiology·S Winegrad
Jun 9, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Emmanuel S BuysKenneth D Bloch
May 4, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Sharon M CawleyKenneth D Bloch
Oct 26, 2013·Resuscitation·Uwe EbmeyerGerburg Keilhoff
Oct 12, 2001·European Journal of Heart Failure·D SarkarS E Harding
Jan 2, 2014·Pharmacology & Therapeutics·Lifei TangMark T Ziolo
Apr 15, 2014·European Journal of Pharmacology·Antonia StefaniotouTheodoros Xanthos
Jan 21, 2010·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·R A TioD J van Veldhuisen
May 25, 2012·Heart Failure Reviews·Mihai GheorghiadeUNKNOWN Academic Research Team in Heart Failure (ART-HF)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.